Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Trastuzumab dttb coupon?Febuxostat 80 mg price?Average cost of doxycycline?How much does tyvaso cost?How much does tesamorelin cost?
See the DrugPatentWatch profile for Digoxin
Digoxin is a cardiac glycoside. It works mainly on the heart to slow the heart rate and increase the force of contraction.
Digoxin is commonly classified as: - A cardiac glycoside (pharmacologic class) - A positive inotrope used for heart conditions (functional use)
Digoxin is grouped with other cardiac glycosides because it inhibits the Na+/K+ ATPase pump in heart cells, which indirectly increases intracellular calcium. That increased calcium is what boosts contraction strength and helps control heart rate.
Digoxin’s medical uses (commonly atrial fibrillation/flutter for rate control and certain types of heart failure to improve symptoms) don’t change its core drug class: it remains a cardiac glycoside based on its mechanism.
Digoxin is often used for rhythm- and rate-related indications (especially atrial fibrillation/flutter), so it’s sometimes grouped with antiarrhythmic medicines in practice. But mechanistically and pharmacologically, it is still classified as a cardiac glycoside.
Other Questions About Digoxin :